Pictorial Essay: Imaging of Peripheral Nerve Sheath Tumours  by Chee, Daniel W.Y. et al.
Canadian Association of Radiologists Journal 62 (2011) 176e182
www.carjonline.orgMusculoskeletal Radiology / Radiologie musculo-squelettique
Pictorial Essay: Imaging of Peripheral Nerve Sheath Tumours
Daniel W. Y. Chee, MBBCh, MMed, FRCRa, Wilfred C. G. Peh, MD, FRCP, FRCRa,*,
Tony W. H. Shek, MBBS, FRCPAb
aDepartment of Diagnostic Radiology, Alexandra Hospital, Singapore, Republic of Singapore
bDepartment of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, ChinaAbstract
Peripheral nerve sheath tumours (PNST) may be benign or malignant. Benign PNSTs include neurofibroma and schwannoma. Neurogenic
tumours share certain characteristic imaging features, suggested by a fusiform-shaped mass with tapered ends, the ‘‘split-fat’’ sign, atrophy of
the muscles supplied by the involved nerve, the ‘‘fascicular sign,’’ and the ‘‘target sign’’; these imaging features are best demonstrated on
magnetic resonance imaging. This pictorial essay emphasizes the characteristic signs and distinguishing features of PNSTs on imaging.Re´sume´
Les tumeurs des gaines des nerfs pe´riphe´riques peuvent eˆtre be´nignes ou malignes. Parmis les be´nignes, on compte les neurofibromes
et les schannomes. Les tumeurs neuroge`nes partagent certaines caracte´ristiques a` l’imagerie, soit une masse fusiforme (atte´nue´es aux deux
extre´mite´s), le signe « split-fat » (couronne pe´riphe´rique de tissus adipeux), une atrophie des muscles innerve´s par le nerf atteint, le signe
« fasciculaire » et le signe « de la cible ». Ces caracte´ristiques sont mieux vues a` l’imagerie par re´sonnance magne´tique. Cet article mets
en e´vidence les signes caracte´ristiques et distinctifs des tumeurs des gaines des nerfs pe´riphe´riques a` l’imagerie.
 2011 Canadian Association of Radiologists. All rights reserved.
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Peripheral nerve sheath tumours (PNST) are divided into represent slightly more than 5% of benign soft-tissue
2 major categories: benign and malignant. Benign PNSTs
include schwannomas and neurofibromas. Malignant PNST
is now the general term used to describe malignant entities
such as malignant schwannoma and neurofibrosarcoma.
Malignant PNST is the preferred terminology because the
cell of origin in these lesions often is unknown [1]. Both
benign and malignant PNSTs may be associated with
neurofibromatosis. The incidence of PNSTs is approximately
1 per 100,000 individuals per year [2]. This pictorial essay
illustrates the imaging characteristics of the various types of
PNSTs, with particular attention to key distinguishing
features on magnetic resonance (MR) imaging.
Neurofibromas
Neurofibromas most commonly affect patients 20e30
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doi:10.1016/j.carj.2010.04.009neoplasms [4,5]. Three subtypes of neurofibromas have
been described: localized, diffuse, and plexiform. Most
lesions are solitary (localized form), which represent about
90% of these neurofibromas. Up to 10% of neurofibromas are
associated with neurofibromatosis (NF). This comorbidity
results in a markedly increased risk of malignant trans-
formation. Localized neurofibromas often arise from cuta-
neous nerves, with occasional involvement of deep-seated
larger nerves; they are usually slow growing. The diffuse
subtype commonly originates from the nerves in the subcu-
taneous tissues of the head and neck, and primarily affects
children and young adults. Unlike the more-common focal
neurofibroma, diffuse neurofibromas are often ill defined and
spread extensively along connective tissue septa and in-
between adipose tissue. Diffuse neurofibroma typically
involves the subcutaneous tissue down to the level of the
fascia [6].
Neurologic symptoms are likely when a neurofibroma
originates from a deep-seated nerve, whereas superficial
neurofibromas are usually small painless masses. The plex-
iform subtype manifests as a diffuse tumour with tortuousll rights reserved.
Figure 1. Median nerve schwannoma in a 35-year-old man, demonstrating the typical fusiform shape with tapered ends. (A) Coronal T1-weighted (W)
magnetic resonance (MR) image of the wrist, showing a well-circumscribed fusiform isointense (compared with skeletal muscle) mass with tapered ends that
arise from the median nerve at the level of the distal ulna (proximal to the ulna-carpal joint). (B) Coronal T2-W fat-suppressed MR image, showing the
fusiform-shaped mass to be of heterogeneously hyperintense T2 signal, more clearly showing it to arise from the median nerve compared with the T1 image.
(C) Coronal contrast-enhanced T1-W fat-suppressed MR image, showing heterogeneous enhancement of the mass. (D) Sagittal T2-W fat-suppressed MR
image, showing the mass to be eccentric in location in relation to the median nerve, typical of a schwannoma.
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results in a serpentine ‘‘bag of worms’’ appearance on gross
inspection and cross-sectional imaging. Plexiform neurofi-
bromas are pathognomonic for neurofibromatosis type 1
(NF1). On pathologic examination, neurofibromas are inti-
mately associated with their nerve of origin and are not
encapsulated, unlike schwannomas. As a result, complete
excision of a neurofibroma requires removal of the nerve.Figure 2. Ulnar nerve schwannoma in a 22-year-old woman. (A) Axial T1-wei
isointense (compared with skeletal muscle) mass arising from the ulnar nerve a
T2-W fat-suppressed MR image, showing the lesion to be heterogeneously hy
heterogeneous enhancement. (D) Photomicrograph (H&E, original magnificationSchwannomas
Schwannomas most commonly affect patients 20e40
years of age and constitute about 5% of benign soft-tissue
neoplasms [7,8]. Males and females are affected equally.
The commonly involved sites include the spinal and
sympathetic roots of the head and neck, as well as nerves in
the flexor surfaces of the upper and lower extremities (inghted (W) magnetic resonance (MR) image, showing a well-circumscribed
t the level of the distal ulna (proximal to the ulnar-carpal joint). (B) Axial
perintense. (C) Axial contrast-enhanced T1-W MR image, showing mild
 20) of the excised specimen confirms the diagnosis of schwannoma.
Figure 3. Tibial neurogenic tumour in a 48-year-old man. (A) Coronal proton-density magnetic resonance (MR) image, showing a well-circumscribed mass that
is slightly hyperintense compared with skeletal muscle; it arises from the tibial nerve. (B) Axial T2-weighted (W) fat-suppressed MR image, showing the lesion
to be homogeneously hyperintense. (C) Coronal contrasteenhanced T1-W fat-suppressed MR image, showing a homogeneous avidly enhancing solid mass
arising from the tibial nerve medial to the talo-calcaneal joint.
Figure 4. Anterior deltoid intramuscular schwannoma in a 21-year-old man, demonstrating the classic split-fat sign and the target sign. (A) Coronal
T1-weighted (W) magnetic resonance (MR) image, showing a well-circumscribed ovoid isointense mass (compared with the skeletal muscle) within the right
deltoid muscle. The tapered rim of hyperintense fat is seen adjacent to the proximal and distal ends of the lesion. (B) Coronal T2-W fat-suppressed MR image,
showing peripheral hyperintense T2 signal intensity, whereas the central area of the lesion is more hypointense, demonstrating the target sign. (C) Coronal
contrast-enhanced T1-W fat-suppressed MR image, showing heterogeneous enhancement that is less avid peripherally. (D) Axial T2-W fat-suppressed MR
image, again demonstrating the target sign, which consists of peripheral hyperintensity and central hypointensity. (E) Axial contrast-enhanced T1-W
fat-suppressed MR image, showing predominantly central heterogeneous enhancement.
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Figure 5. Intramuscular schwannoma in a 26-year-old man who presented
with a painless mass in the posterior compartment of the left thigh, with
images demonstrating a classic split-fat sign. (A) Sagittal T1-weighted (W)
magnetic resonance (MR) image, showing a well-circumscribed ovoid
heterogeneous mass (slightly hyperintense compared with the skeletal
muscle) located within the semitendinosus muscle. The tapered rim of
hyperintense fat is seen adjacent to the proximal and distal ends of the lesion,
typical of the split-fat sign. (B) Sagittal TIRMMR image, showing the lesion
to be heterogeneously hyperintense; the adjacent split-fat sign is present.
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solitary and not associated with NF1. The typical presenta-
tion is a slow-growing, painless, soft-tissue mass. Pain and
neurologic symptoms are unusual except in large tumours.
About 5% of multiple schwannomas are associated with
NF1. Vestibular schwannomas are the most-common and
recognized feature of neurofibromatosis type 2 (NF2), and
leads to significant morbidity. Dumbbell-shaped spinal cord
schwannomas are also common in NF2. On pathologic
examination, schwannomas are fusiform masses eccentri-
cally located adjacent to the involved nerve, and both the
schwannoma and the affected nerve are contained within
a true capsule, the epineurium. Schwannomas are composed
primarily of Schwann cells. Treatment of schwannoma is
usually surgical resection. The affected nerve is usually
surgically separable from the tumour, with sparing of the
parent nerve and its function. Recurrence is unusual and
malignant transformation is extremely rare.
Malignant PNSTs
Malignant PNSTs usually affect patients 20e50 years of
age, with no significant sex predilection, and account for
about 5%e10% of all soft-tissue sarcomas [5,9]. A high
proportion (about 50%) of malignant PNSTs occurs in
association with NF1. However, only a small proportion of
patients with NF1 (about 5%) develop malignant peripheral
nerve sheath tumours [7,8]. A malignant PNST generally
presents as a soft-tissue mass that involves the major nerves
and presents with pain and neurologic symptoms. A
secondary malignant PNST may arise after radiation treat-
ment, with a latent period that exceeds 10 years [7,8].
Imaging Characteristics of PNSTs
Radiographs of PNSTs frequently are normal. Calcifica-
tion, which may be chondroid, osteoid, or amorphous, is
uncommon and mild in extent when present [10,11]. Bone
involvement from either extrinsic erosion or invasion is
unusual. On computed tomography (CT), neurofibromas are
seen as a well-defined, soft-tissue mass that is hypodense
relative to muscle. Low attenuation is frequently observed
(5e25 HU) because of the high lipid content of myelin from
Schwann cells. On CT, neurofibromas usually show little or
no enhancement. Ultrasonographic findings consist of a well-
defined homogeneous, hypoechoic, fusiform-shaped mass
that is oriented longitudinally in the nerve distribution, with
tapered ends contiguous with the parent nerve. It may show
posterior acoustic enhancement and simulate a cyst. An
ultrasonographic target sign may be seen in neurofibromas
with a hypoechoic peripheral zone and a hyperechoic central
zone. Angiography of deep PNSTs may demonstrate
displacement of major vascular structures around the parent
nerve. Increased vascularity often is observed but variable
and is typically more prominent in malignant PNSTs. An
angiographic feature described to be characteristic is the
presence of tortuous corkscrew nutrient feeding vessels at theupper and lower poles of the tumour [12,13], which represent
hypertrophy of nutrient nerve.
MR imaging is currently the modality of choice for
evaluation of PNSTs. Classic MR imaging findings, if
present, are often highly suggestive of a benign neurogenic
tumour. On MR imaging, neurogenic tumours are seen as
a fusiform-shaped mass with tapered ends that are low-to-
intermediate signal intensity on T1-weighted images and
high signal intensity on T2-weighted images (Figure 1). The
diagnostic confidence is increased if the mass arises from the
anatomic location of a known nerve (Figure 2). The signal
intensity on T2-weighted images may be either homoge-
neously hyperintense (Figure 3) or show a characteristic MR
target sign that consists of high signal intensity in the
periphery and low signal intensity in the central region of the
lesion (Figure 4). This MR imaging finding corresponds with
pathologic findings to fibrous tissue (with high collagen
content) centrally and more myxoid tissue peripherally. Such
a mass, if associated with muscular fatty atrophy that is best
seen on T1-weighted images in a typical nerve distribution,
is indicative of a PNST. Muscle atrophy is not commonly
seen in other soft-tissue tumours.
The split-fat sign (best appreciated on T1-weighted
images) represents a rim of fat that surrounds the tumour
(Figures 4 and 5), particularly in relation to the proximal and
distal portion of the nerve. This sign is not specific for
PNSTs but is suggestive that the tumour originates in the
intermuscular space, in which neurogenic tumours are the
most-frequent cause. This sign is more common in benign
PNSTs and lesions that arise from large nerves. Malignant
PNSTs less frequently demonstrate a complete fat rim
because of its more aggressive and infiltrative growth pattern.
Another MR imaging sign that suggests a neurogenic tumour
Figure 6. Ulnar and median neurofibromas in a 15-year-old girl, with images demonstrating the magnetic resonance (MR) fascicular sign. (A) Sagittal T1-
weighted (W) MR image, showing a well-circumscribed elongated mass arising from the median nerve at the level of the carpal bones, which is isointense
to skeletal muscle. (B) Sagittal T2-W fat-suppressed MR image, showing the lesion to be heterogeneous hyperintense, with thickened hypointense strands
within. (C) Axial T1-W MR image, showing 2 well-circumscribed isointense lesions, which correspond to the volar-sided nerves of the wrist; the more radial
lesion is the median neurofibroma, whereas the more ulnar lesion is the ulnar neurofibroma. (D) Axial T2-W fat-suppressed image, showing the median and
ulnar neurofibromas as hyperintense masses with speckled central areas of hypointense foci; these represent thickened fascicles. (E) Coronal T2-W fat-
suppressed MR image, showing both the median and ulnar neurofibromas in the same plane. (F) Axial contrast-enhanced T1-W fat-suppressed MR image,
showing heterogeneously enhancement of the ulnar and median neurofibromas.
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Figure 7. Thenar intramuscular schwannoma in a 74-year-old man. (A) Radiograph of the left hand, showing a vague nonspecific soft-tissue mass in the first
web space, with no abnormal bony changes. (B) Axial T1-weighted (W) magnetic resonance (MR) image of the left hand, showing a heterogeneously
hyperintense nonspecific lobulated mass (compared with skeletal muscle) located within the thenar muscle. (C) Axial T2-W fat-suppressed MR image, showing
the well-circumscribed lesion to be heterogeneously hyperintense. (D) Axial contrast-enhanced T1-W fat-suppressed MR image, showing heterogeneous
enhancement of the lesion. There are no specific features to suggest a neurogenic tumour, and pathologic examination is required. Diagnosis of thenar
schwannoma was confirmed, by histologic examination, after excision.
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hypointense foci interspersed within a hyperintense area on
T2-weighted or proton-density weighted MR images (Figure
6). This sign may be seen in both superficial and deep-seated
lesions, which corresponds to the fascicular bundles seen, on
pathologic examination, in neurogenic tumours. Imaging
findings of schwannomas and neurofibromas are often
similar and, in many cases, cannot be distinguished from
each other. When the parent nerve is identified, an eccen-
trically located tumour suggests a schwannoma (Figure 1D),
whereas a centrally located soft-tissue mass suggests
a neurofibroma (Figure 6). A heterogeneous appearance with
degeneration and cystic changes are much more frequently
seen in schwannomas than in neurofibromas.
Malignant PNSTs tend to be larger (>5 cm) and may
demonstrate ill-defined margins, which suggest infiltration of
adjacent tissues and associated oedema. Heterogeneity with
central necrosis is frequently seen in malignant lesions thanin benign lesions. The pattern of enhancement is variable in
both benign (Figures 1C, 2C, 3C, 6E, and 6F) and malignant
PNSTs. In general, increased heterogeneous enhancement,
particularly peripheral nodular enhancement, suggests
malignant PNSTs. Lesions that demonstrate the target sign
typically enhance more avidly in the central region (Figure 4,
C and E). Irregular infiltrative tumour borders and internal
heterogeneity are more common in malignant PNSTs but
may also be present in benign neurofibromas [14]. Unless
there are distinctive characteristics, imaging is not entirely
reliable in differentiating benign from malignant PNSTs,
with the most-common abnormality detected on imaging of
PNSTs being a nonspecific soft-tissue mass (Figure 7). If the
lesion does not have these classic imaging findings, or, if
there is any clinical or radiologic feature that raises the
possibility of malignancy, then a carefully planned biopsy
specimen should be obtained in consultation with the refer-
ring surgeon.
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In summary, MR imaging is the modality of choice for
evaluation of suspected neurogenic tumours. If present, then
this constellation of MR imaging findings are highly
suggestive of a benign neurogenic tumour: fusiform-shaped
soft-tissue mass with tapered ends that are contiguous with
the parent nerve, associated muscular fatty atrophy in
a typical nerve distribution, complete split-fat sign, target
sign, and fascicular sign. There are no clear imaging criteria
to distinguish between benign and malignant PNSTs. If the
characteristic findings described for benign PSNT are not
present, then a malignant PNST or other soft-tissue tumours
cannot be excluded, and a carefully planned biopsy specimen
should be obtained.
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